The changing epidemiology of human monkeypox—A potential threat? A systematic review
By E. Bunge, B. Hoet, Liddy Chen, F. Lienert, H. Weidenthaler, L. Baer, R. Steffen. medRxiv, 2021
1,581 citations recorded by the source corpus.
Monkeypox, a zoonotic disease caused by an orthopoxvirus, results in a smallpox-like disease in humans. Since monkeypox in humans was initially diagnosed in 1970 in the Democratic Republic of the Congo (DRC), it has spread to other regions of Africa (primarily West and Central), and cases outside Africa have emerged in recent years. We conducted a systematic review of peer-reviewed and grey literature on how monkeypox epidemiology has evolved, with particular emphasis on the number of confirmed, probable, and/or possible cases, age at presentation, mortality, and geographical spread. The review is registered with PROSPERO (CRD42020208269). We identified 48 peer-reviewed articles and 18 grey literature sources for data extraction. The number of human monkeypox cases has been on the rise since the 1970s, with the most dramatic increases occurring in the DRC. The median age at presentation has increased from 4 (1970s) to 21 years (2010-2019). There was an overall case fatality rate of 8.7%, with a significant difference between clades - Central African 10.6% (95% CI: 8.4% - 13.3%) vs. West African 3.6% (95% CI: 1.7% - 6.8%). Since 2003, import- and travel-related spread outside of Africa has occasionally resulted in outbreaks. Interactions/activities with infected animals or individuals are risk behaviors associated with acquiring monkeypox. Our review shows an escalation of monkeypox cases, especially in the highly endemic DRC, a spread to other countries, and a growing median age from young children to young adults. These findings may be related to the cessation of smallpox vaccination, which provided some cross-protection against monkeypox, leading to increased human-to-human transmission. The appearance of outbreaks beyond Africa highlights the global relevance of the disease. Increased surveillance and detection of monkeypox cases are essential tools for understanding the continuously changing epidemiology of this resurging disease.
Subfields: Epidemiology, Plant Science, Virology
View Paper: https://www.semanticscholar.org/paper/5dd0f5da373824c8507763e52464f958e3020768
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- W. Burmeister
- A. Antinori
- J. Rockstroh
- S. Walmsley
- G. Schoehn
- Stephanie Hutin
- W. Ling
- C. Grimm
Citations in the corpus
- Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. (2022, background): “screened (%) 109/377 (29) Gonorrhea 32/377 (8) Chlamydia 20/377 (5) Syphilis 33/377 (9) Herpes simplex virus infection 3/377 (1) Lymphogranuloma venereum 2/377 (1) Chlamydia and gonorrhea 5/377 (1) Other or not stated 14/377 (4) HIV test taken — no.”
- The Vaccinia Virus DNA Helicase Structure from Combined Single-Particle Cryo-Electron Microscopy and AlphaFold2 Prediction (2022, background): “So far, there have been little casualties outside Africa, whereas within Africa, the West African and the Congo strains have difficult to estimate mortality rates in the range of 2–7% and 8–13%, respectively [2].”